Biohacking Kompakt

Treatment & Procedure

Screenings

Equipment

Compact screenings promise a quick overview of fatty acids, nutrients and other values from a few drops of blood. The laboratory technology behind them can be reliable. Whether the number is of any use to you depends on whether a proven consequence follows from it.

In short

Such screenings measure selected values from a small blood sample, for example the fatty acid profile or nutrient status, and are self-pay services. With a validated method, dried capillary blood samples can agree well with a venous blood sample. In large observational studies, higher omega-3 levels go along with lower mortality. The catch: in a Cochrane review of 17 studies, general health checks did not lower mortality, and according to the IGeL-Monitor the benefit of vitamin D screening without symptoms is unclear.

What is measured

Typically, a small blood sample is taken from the fingertip, dried on filter paper and sent to the laboratory. Popular options are fatty acid profiles with the omega-3 index, that is, the proportion of the omega-3 fatty acids EPA and DHA in red blood cells, plus vitamin D, other nutrients or inflammation markers. The results arrive digitally, often with traffic-light colors and recommendations.

The difference from diagnostics matters. A screening looks for abnormalities in people without symptoms. That only makes sense if an abnormal value leads to a measure that demonstrably helps, and a normal value spares you something.

What the statutory check-up already covers

Statutory health insurance pays for a health examination: once between the ages of 18 and 34, and every three years from 35. It includes medical history, physical examination, blood pressure, vaccination status and advice on risk factors. From 35, urine, blood glucose and cholesterol are added, plus a one-time test for hepatitis B and C. Men aged 65 and over can have a one-time ultrasound examination for an enlargement of the abdominal aorta. Before you pay yourself, it is worth checking what is already covered.

What it costs

Compact analyses are self-pay services, and providers set their own prices. As a reference point, the IGeL-Monitor gives laboratory costs of 27.98 to 32.18 euros for a single vitamin D measurement, excluding consultation and blood sampling. Panels with several values cost correspondingly more.

How to recognize a reputable offer

Ask which laboratory does the measuring and whether the method is validated for capillary blood. Good providers state reference ranges and say where they come from. They explain in advance what consequence an abnormal value would have, have results assessed by a doctor and do not sell you the matching product at the same time. And they say openly that a screening is not a diagnosis.

What is well supported

The measurement technology can work. In a validation study with 44 healthy people, vitamin D values from dried capillary blood, after conversion, were within 20 percent of the venous blood value in 90 percent of samples, and the classification as sufficient or deficient largely matched.

The omega-3 index also measures something relevant. In a pooled analysis of 17 cohort studies with 42,466 people, those with the highest omega-3 levels had 15 to 18 percent lower mortality over a median of 16 years than those with the lowest.

What the studies show

Cochrane: general health checks

Review of 17 randomized trials, 15 with outcome data and 251,891 participants. Those invited to health checks did not die less often than the control group; the relative risk was 1.00. Cancer and cardiovascular mortality, heart attacks and strokes did not change either, with high to moderate certainty of evidence.

Omega-3 levels and mortality

Pooled analysis of 17 prospective cohorts with 42,466 people. Higher blood levels of long-chain omega-3 fatty acids went along with lower all-cause, cardiovascular and cancer mortality. This is an association, not proof that raising the value lowers mortality.

VITAL: omega-3 as a supplement

Randomized trial with 25,871 participants, 1 gram of omega-3 per day versus placebo over a median of 5.3 years. The primary endpoints, major cardiovascular events and cancer, were not met; the hazard ratio for cardiovascular events was 0.92, not significant. Heart attacks, a secondary endpoint, were less frequent, with a hazard ratio of 0.72.

Where the data stop

The step from value to benefit is usually missing. In randomized trials, general health checks did not lower mortality, but they did lead to more diagnoses. For the omega-3 index, the association with mortality is observed, yet the largest supplement trial missed its main goals. For vitamin D screening in people without symptoms, the IGeL-Monitor found no studies showing a benefit.

Then there is the question of method: the good agreement between capillary and venous blood applies to validated procedures. Nothing can be said about a specific compact panel without published validation.

Status, approval and legal

The general health examination is covered by statutory health insurance under the guideline of the German Federal Joint Committee (G-BA). Additional compact analyses without a suspected illness are self-pay services. If there is a specific suspicion, for example of vitamin D deficiency, the insurer covers the measurement.

Safety

Taking the sample itself is harmless. The risks lie in the interpretation: a false abnormal value leads to worry, follow-up examinations or unnecessary supplements, a falsely reassuring value to missed symptoms. Do not treat yourself on the basis of a screening value; have abnormal findings assessed by a doctor and, where appropriate, confirmed with a standard method.

Frequently asked questions about screenings

What is an omega-3 index?

The proportion of the omega-3 fatty acids EPA and DHA in the membranes of red blood cells. In large observational studies, higher values go along with lower mortality. Whether deliberately raising the value brings this benefit is not established.

Are fingertip blood tests reliable?

With a validated method they can agree well with venous blood; in one study on vitamin D, 90 percent of values were within 20 percent. But this applies only to the specific method tested. Ask the provider about the validation.

Which preventive check-ups does statutory health insurance pay for?

One health examination between the ages of 18 and 34 and every three years from 35, from 35 with blood glucose, cholesterol and urine. In addition there is a one-time hepatitis test and, for men aged 65 and over, an ultrasound of the abdominal aorta. Insurers pay for further values when there is a specific suspicion.

Is an annual all-round check-up worthwhile?

Not for life expectancy, according to the evidence. A Cochrane review of 17 studies found no lower mortality from general health checks. Targeted early detection for specific risks is a different matter.

Should I have my vitamin D level tested?

Without symptoms or risk factors, the benefit is unclear according to the IGeL-Monitor. It puts the laboratory costs for one value at 27.98 to 32.18 euros. If there is a justified suspicion, the insurer pays.

What do I do with an abnormal screening value?

Have it assessed by a doctor and, if in doubt, confirmed with a standard method. A single value is a snapshot. Do not start high-dose self-treatment on the basis of a screening.

Related

Sources

Open in the database – with search, filters and comparison (German app)

Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.